Is IUGNF or DIVO a better dividend investment in 2026?

IUGNF currently yields 1788.91% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: IUGNF offers higher current income.

What is the dividend yield difference between IUGNF and DIVO?

IUGNF has a forward dividend yield of 1788.91% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 1782.42 percentage points.

Home › Compare › IUGNF vs DIVO

IUGNF vs DIVO: Dividend Comparison 2026

IUGNF yields 1788.91% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IUGNF wins by $3531675981.97M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IUGNF

● Live price

1788.91%

Share price

$0.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3531675982.01M

Annual income

$3,181,793,952,650,469.00

Full IUGNF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — IUGNF vs DIVO

📍 IUGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IUGNF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IUGNF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IUGNF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IUGNF

Annual income on $10K today (after 15% tax)

$152,057.25/yr

After 10yr DRIP, annual income (after tax)

$2,704,524,859,752,898.50/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, IUGNF beats the other by $2,704,524,859,752,064.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IUGNF + DIVO for your $10,000?

IUGNF: 50%DIVO: 50%

100% DIVO50/50100% IUGNF

Portfolio after 10yr

$1765837991.02M

Annual income

$1,590,896,976,325,725.20/yr

Blended yield

90.09%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IUGNF buys

DIVO buys

No recent congressional trades found for IUGNF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIUGNFDIVO

Forward yield	1788.91% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3531675982.01M ✓	$30.7K
Annual income after 10y	$3,181,793,952,650,469.00 ✓	$981.68
Total dividends collected	$3506616114.25M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IUGNF vs DIVO ($10,000, DRIP)

Year	IUGNF Portfolio	IUGNF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$189,591	$178,890.88	$11,349	$649.42	+$178.2K → IUGNF
2	$3,372,589	$3,169,726.93	$12,833	$688.83	+$3.36M → IUGNF
3	$56,305,450	$52,696,779.78	$14,459	$727.90	+$56.29M → IUGNF
4	$882,465,426	$822,218,594.62	$16,238	$766.49	+$882.45M → IUGNF
5	$12,987,684,313	$12,043,446,306.47	$18,179	$804.47	+$12987.67M → IUGNF
6	$179,550,479,073	$165,653,656,858.63	$20,293	$841.71	+$179550.46M → IUGNF
7	$2,332,406,409,977	$2,140,287,397,368.80	$22,591	$878.14	+$2332406.39M → IUGNF
8	$28,479,672,886,997	$25,983,998,028,321.59	$25,087	$913.65	+$28479672.86M → IUGNF
9	$326,992,550,798,860	$296,519,300,809,773.56	$27,791	$948.18	+$326992550.77M → IUGNF
10	$3,531,675,982,005,250	$3,181,793,952,650,469.00	$30,718	$981.68	+$3531675981.97M → IUGNF

IUGNF vs DIVO: Complete Analysis 2026

IUGNF — Stock

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research collaboration with Celularity Inc. to develop the combination of Imugene's CD19 oncolytic virus technology and Celularity's CD19 targeting allogeneic chimeric antigen receptor T-cell therapy, CyCART-19 for the treatment of solid tumors; and has a strategic collaboration with Eureka Therapeutics, Inc. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.

Full IUGNF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this IUGNF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IUGNF vs SCHD IUGNF vs JEPI IUGNF vs O IUGNF vs KO IUGNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.